The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR

Virology

Volumn 240, Issue 2, 1998, Pages 359-365

  Delius, Hajo ^a   Saegling, Bettina ^a   Bergmann, Krister ^a   Shamanin, Vladimir ^a   De Villiers, Ethel Michele ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC CONSERVATION; GENOME; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; VERRUCA; VERRUCA VULGARIS VIRUS;

EID: 0032518604     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8943     Document Type: Article

References (38)

1. Abroi A., Kurg W., Ustav M. Transcriptional and replicational activation functions in the BPV 1 E2 protein are encoded by different structural determinants. J. Virol. 70:1996.
2. Banks L., Edmonds C., Vousden K. H. Ability of the HPV 16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene. 5:1990;1383-1389.
3. Barbosa M. S., Edmonds C., Fisher C., Schiller J. T., Lowy D. R., Vousden K. H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:1990;153-160.
4. Bergmann K., Hoppe F., He Y., Helms J., Müller-Hermelink H.-J., Stremlau A., de Villiers E-M. Human-papillomavirus DNA in cholesteatomas. Int. J. Cancer. 59:1994;463-466.
5. Berkhout R. J., Tieben L. M., Smits H. L., Bavinck J. N., Vermeer B. J., ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol. 33:1995;690-695.
6. Brokaw J. L., Yee C. L., Münger K. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Virology. 205:1994;603-607.
7. Chan S-Y., Delius H., Halpern A. L., Bernard H-U. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny and taxonomy. J. Virol. 69:1995;3074-3083.
8. Corina K., Grossman S. R., Barsoum J., Prakash S. S., Androphy E. J., Pepinsky R. B. The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain. Virology. 197:1993;391-396.
9. Delius H., Hofmann B. Primer-directed sequencing of human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:1994;13-31.
10. de Villiers E-M. Human papillomaviruses: An update. Curr. Top. Microbiol. Immunol. 186:1994;1-12.
11. de Villiers E-M., Lavergne D., McLaren K., Benton C. Prevailing papillomavirus types in nonmelanoma carcinomas of the skin in renal allograft recipients. Int. J. Cancer. 73:1997;356-361.
12. Doorbar J., Myers G. The E4 Proteins. Human Papillomaviruses 1996. 1996;Los Alamos Natl. Laboratory, Los Alamos. p. III.
13. Egawa K., Delius H., Matsukura T., Kawashima M., de Villiers E-M. Two novel types of human papillomavirus, HPV 63 and HPV 65: Comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology. 194:1993;789-799.
14. Favre M., Croissant O., Orth G. Human papillomavirus type 29 (HPV-29), an HPV type cross-hybridizing with HPV-2 and with HPV-3-related types. J. Virol. 63:1989;4906.
15. Favre M., Obalek S., Jablonska S., Orth G. Human papillomavirus type 49, a type isolated from flat warts of renal transplant patients. J. Virol. 63:1989.
16. Halpern, A. L. Münger, K. 1995, HPV 16 E7: Primary structure and biological properties, In, G. MyersH-U. BernardH. DeliusC. BakerJ. IcenogleA. Halpern, III, Los Alamos Natl. Laboratory, Los Alamos.
17. Hirt L., Hirsch-Behnam A., de Villiers E-M. Nucleotide sequence of human papillomavirus (HPV) type 41: An unusual HPV type without a typical E2 binding site consensus sequence. Virus Res. 18:1990;179-190.
18. Hirsch-Behnam A., Delius H., de Villiers E-M. A comparative sequence analysis of two human papillomavirus (HPV) types 2a and 57. Virus Res. 18:1990;81-98.
19. Huang P. S., Patrick D. R., Edwards G., Goodhart P. J., Huber H. E., Miles L., Garsky V. M., Oliff A., Heimbrook D. C. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol. 13:1993;953-960.
20. Hubbert N. L., Schiller J. T., Lowy D. R., Androphy E. J. Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc. Natl. Acad. Sci USA. 85:1988;5864-5868.
21. Jewers R. J., Hildebrandt P., Ludlow J. W., Kell B., McCance D. J. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1992;1329-1335.
22. Kremsdorf D., Favre M., Jablonska S., Obalek S., Rueda L. A., Lutzner M. A., Blanchet-Bardon C., Van Voorst Vader P. C., Orth G. Molecular cloning and characterization of the genomes of nine newly recognized human papilomavirus types associated with epidermodysplasia verruciformis. J. Virol. 52:1984;1013-1018.
23. McBride A., Myers G. The E2 proteins. Myers G., Halpern A., Baker C., McBride A., Wheeler C., Doorbar J. Human Papillomaviruses 1996. 1996;III15-31 Los Alamos Natl. Laboratory, Los Alamos.
24. O'Connor M., Chan S-Y., Bernard H-U. Transcription factor binding sites in the long control region of genital HPVs. Myers G., Bernard H-U., Delius H., Baker C., Icenogle J., Halpern A. Human Papillomaviruses 1995. 1995;III Los Alamos Natl. Laboratory, Los Alamos.
25. Patrick D. R., Oliff A., Heimbrook D. C. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J. Biol. Chem. 269:1994;6842-6850.
26. Phelps W. C., Bagchi S., Barnes J. A., Raychaudhuri P., Kraus V., Münger K., Howley P. M., Nevins J. R. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:1991;6922-6930.
27. Phelps W. C., Münger K., Yee C. L., Barnes J. A., Howley P. M. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66:1992;2418-2427.
28. Prakash S. S., Grossman S. R., Pepinsky B., Androphy E. J., Laimins L. Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 transactivator. Genes Dev. 6:1992;105-116.
29. Rawls J. A., Pusztai R., Green M. Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: Autonomous protein domains for induction of cellular DNA synthesis and for trans activation. J. Virol. 64:1990;6121-6129.
30. Rho J., Roy-Burman A., Kim H., de Villiers E-M., Matsukura T., Choe J. Nucleotide sequence and phylogenetic classification of human papillomavirus type 59. Virology. 203:1994;158-161.
31. Roberts S., Ashmole I., Gibson L., Rookes S. M., Barton G. J., Gallimore P. H. Mutational analysis of human papillomavirus E4 proteins: Identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J. Virol. 68:1994;6432-6455.
32. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
33. Shamanin V., Delius H., de Villiers E-M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J. Gen. Virol. 75:1994a;1149-1156.
34. Shamanin V., Glover M., Rausch C., Proby C., Leigh I. M., zur Hausen H., de Villiers E-M. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res. 54:1994b;4610-4613.
35. Skiadopoulos M. H., McBride A. A. The BPV-1 E2 transactivator and E2-TR repressor use different nuclear localization signals. J. Virol. 70:1996;1117-1124.
36. Storey A., Almond N., Osborn K., Crawford L. Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J. Gen. Virol. 71:1990;965-970.
37. Tabor S., Richardson C. C. Effect of manganese ions on the incorporation of dideoxynucleotides by bacteriophage T7 DNA polymerase andEscherichia coli. Proc. Natl. Acad. Sci. USA. 86:1989;4076-4080.
38. Watanabe S., Kanda T., Sato H., Furuno A., Yoshiike K. Mutational analysis of human papillomavirus type 16 E7 functions. J. Virol. 64:1990;207-214.